The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea Peptides Lack Reliable Safety Information, Watchdog Warns As unregulated peptides grow in popularity, doctors warn of unknown risks ABC7 San Francisco FDA releases denial letters for unapproved drugs, a step toward transparency Indictment of Osteopathic Physician Signals Shift in Peptide Enforcement Stevens & Lee